Discover 926 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 926
A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for
Parkinson Disease
Location: Portland OR, Seattle WA, Bellevue WA, Los Angeles CA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 40 - 70+
Code: NCT06976268
Phase 2, Phase 3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Tigard OR, Portland OR, Happy Valley OR, Vancouver WA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase 3, Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Tigard OR, Portland OR, Salem OR, Olympia WA, Tacoma WA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase 3, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Tigard OR, San Francisco CA, Palo Alto CA,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Tigard OR, San Mateo CA, La Jolla CA, Aurora CO,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
for
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Location: Tigard OR, Duarte CA, Waukesha WI, Morgantown WV,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07564141
Phase 3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07654361
Phase 3, Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for
Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,
Location: Portland OR, Kirkland WA, Palo Alto CA, Irvine CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT07589595
Phase 2, Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Portland OR, Everett WA, San Jose CA, Clinton UT,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT07226661
Phase 2, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2